133 Publications (Page 5 of 6)
2006
Hope Is the Thing With Feathers
Cripe, Larry D
JAMA, vol. 296, (no. 15), pp. 1815-1816, Oct 18, 2006. | Journal Article
 
In Chronic Lymphocytic Leukemia, Zap70 Identifies a Survival Pathway Signal Cascade Involving p85 PI-3-Kinase, CrkL, and Cbl with Syk En Route to JNK1 and bcl-2
Hartman, Amy DWilson-Weekes, AnniqueCripe, Larry DBennett, BrydonFriedman, GlennWorland, PeterDruker, BrianRen, ShuyueSkorski, Tomasz and Boswell, H. Scott
Blood, vol. 108, (no. 11), pp. 584, 2006-11-16. | Journal Article
 
Loss of Heterozygosity in Bone Marrows of Patients with Iron-Deficiency Anemia
Czader, MagdalenaCzader, MagdalenaCzader, MagdalenaWang, MingshengWang, MingshengWang, MingshengCripe, Larry DCripe, Larry DCripe, Larry DCheng, LiangCheng, LiangCheng, LiangOrazi, AttilioOrazi, Attilio and Orazi, Attilio
Blood, vol. 108, (no. 11), pp. 4863, 2006-11-16. | Journal Article
 
Phase II clinical studies of denileukin diftitox diphtheria toxin fusion protein in patients with previously treated chronic lymphocytic leukemia
Frankel, ArthurFrankel, Arthur ESurendranathan, AshaSurendranathan, AshaBlack, Jennifer HBlack, Jennifer HWhite, AngelaWhite, AngelaGanjoo, KristenGanjoo, KristenCripe, Larry D and Cripe, Larry D
Cancer, vol. 106, (no. 10), pp. 2164, 15 May 2006. | Journal Article
 
Phase I/II Pharmacodynamic Study of the P-Glycoprotein (Pgp) Inhibitor Zosuquidar Administered by Continuous Infusion (CIV) with Daunorubicin (DNR) and Cytarabine (ARA-C) as Primary Therapy in Older Patients with Acute Myeloid Leukemia (AML)
Lancet, JeffreyBaer, Maria RCripe, Larry DList, Alan FMarcelletti, John FMultani, Pratik S and Sikic, Branimir I
Blood, vol. 108, (no. 11), pp. 422, 2006-11-16. | Journal Article
 
Phase I/II, Randomized, MultiCenter, Dose-Ascension Study of the p38MAPK Inhibitor Scio-469 in Patients with Myelodysplastic Syndrome (MDS)
Sokol, LubomirCripe, LarryKantarjian, HagopSekeres, Mikkael AParmar, SimritGreenberg, PeterGoldberg, StuartBhushan, VikasShammo, JamileHohl, RaymondLi, Yu-PingLowe, AnnZhu, Joy and List, Alan
Blood, vol. 108, (no. 11), pp. 2657, 2006-11-16. | Journal Article
 
Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997
Cripe, Larry DRader, KevinTallman, Martin SGordon, Michael SPaietta, Elisabeth MBennett, John MNeuberg, Donna SLitzow, Mark RO'Brien, Timothy E and Rowe, Jacob M
Leukemia Research, vol. 30, (no. 7), pp. 823-827, 2006. | Journal Article
2005
12- O-Tetradecanoylphorbol-13-acetate in acute myeloid leukemia
Chan, Rebecca J and Cripe, Larry D
Leukemia Research, vol. 29, (no. 10), pp. 1108, 2005. | Journal Article
 
A Music Imagery Intervention for Adults with Acute Leukemia in Protective Environments
Burns, Debra SBurns, Debra SAzzouz, FaouziAzzouz, FaouziHincher, KatieHincher, KatieRutledge, CherylRutledge, CherylMonahan, PatrickMonahan, PatrickCripe, Larry D and Cripe, Larry D
Blood, vol. 106, (no. 11), pp. 3130, 2005-11-16. | Journal Article
 
A phase II study of single agent gemcitabine in relapsed or refractory follicular or small lymphocytic non-Hodgkin lymphomas: a Hoosier Oncology Group Study
Ganjoo, KristenGanjoo, Kristen NRobertson, Michael JRobertson, Michael JFisher, WilliamFisher, WilliamJung, Sin HoJung, Sin-HoMcClean, JohnMcClean, JohnHuh, Sang YoonHuh, Sang YBufill, JoseBufill, JoseWilliams, SheronWilliams, SheronCripe, Larry D and Cripe, Larry D
American journal of clinical oncology, vol. 28, (no. 2), pp. 172, 2005-Apr. | Journal Article
 
A Randomized, Open-Label Study of Lestaurtinib (CEP-701), an Oral FLT3 Inhibitor, Administered in Sequence with Chemotherapy in Patients with Relapsed AML Harboring FLT3 Activating Mutations: Clinical Response Correlates with Successful FLT3 Inhibition
Levis, MarkSmith, B. DouglasBeran, MiloslavBaer, Maria RErba, Harry PCripe, LarryCoutre, StevenAdvani, AnjaliPerl, AlexanderDevetten, MarcelStuart, RobertTallman, Martin SBrown, PeterTremmel, Lothar and Small, Donald
Blood, vol. 106, (no. 11), pp. 403, 2005-11-16. | Journal Article
 
In AML, Cbl Serves as Nexus for Signaling from Flt3, and Is Required for Coupling JNK1 in a Pathway of Survival and Proliferation Involving c-jun/AP-1
Hartman, Amy DHartman, Amy DWilson-Weekes, AnniqueWilson-Weekes, AnniqueSuvannasankha, AttayaSuvannasankha, AttayaBurgess, Gem SBurgess, Gem SHincher, Kathryn JHincher, Kathryn JCripe, Larry DCripe, Larry DBoswell, H. Scott and Boswell, H. Scott
Blood, vol. 106, (no. 11), pp. 1203, 2005-11-16. | Journal Article
 
Oncologist Assisted Spiritual Intervention Study (OASIS): patient acceptability and initial evidence of effects.
Kristeller, Jean LMARK, R. HRhodes, MarkCRIPE, LARRY DCripe, Larry DSheets, Virgil and VIRGIL, S. H
International journal of psychiatry in medicine, vol. 35, (no. 4), pp. 329-347, 2005. | Journal Article
 
Very Poor Survival of Patients with AML Who Relapse after Achieving a First Complete Remission: The Eastern Cooperative Oncology Group Experience
Rowe, Jacob MLi, XiaochunCassileth, Peter AAppelbaum, Frederick RSchiffer, Charles AWiernik, Peter HLitzow, Mark RCripe, Larry DLazarus, Hillard MPaietta, ElisabethDewald, Gordon WWeinstein, Howard JOgden, Angela KWoods, William GShepherd, LoisFeusner, James HBloomfield, Clara D and Tallman, Martin S
Blood, vol. 106, (no. 11), pp. 546, 2005-11-16. | Journal Article
2004
Phase II study of low-dose topotecan in myelodysplastic syndromes: a Hoosier Oncology Group (HOG) study,
Vaena, Daniel AWalker, P.Pennington, K.Stephens, A.Stender, MJYiannoutsos, Constantin TYoung, C.Stoner, C. and Cripe, Larry D
Leukemia Research, vol. 28, (no. 1), pp. 49-52, 2004. | Journal Article
2003
Low expression of the myeloid differentiation antigen CD65s, a feature of poorly differentiated AML in older adults: study of 711 patients enrolled in ECOG trials
Paietta, Elisabeth MNeuberg, Donna SBennett, John MDewald, Gordon WRowe, Jacob MCassileth, Peter ACripe, Larry DTallman, Martin S and Wiernik, Peter H
Leukemia, vol. 17, (no. 8), pp. 1544-1550, 2003. | Journal Article
 
Teaching Patients How to Improve Communication with their Health Care Providers: A Unique Workshop Experience
Fisch, MichaelFisch, MichaelCohen, Marlene ZZichi Cohen, MarleneRutledge, CherylRutledge, CherylCripe, Larry D and Cripe, Larry D
Journal of cancer education : the official journal of the American Association for Cancer Education, vol. 18, (no. 4), pp. 193, 2003-Winter. | Journal Article
2002
Thrombopoietin Administered During Induction Chemotherapy to Patients With Acute Myeloid Leukemia Induces Transient Morphologic Changes That May Resemble Chronic Myeloproliferative Disorders
Douglas, VKTallman, Martin SCripe, Larry D and Peterson, Lo Ann C
American Journal of Clinical Pathology, vol. 117, (no. 6), pp. 844-850, 2002. | Journal Article
 
Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin's lymphoma.
Witzig, Thomas EFlinn, Ian WGordon, Leo IEmmanouilides, ChristosCzuczman, Myron SSaleh, Mansoor NCripe, LarryWiseman, GregoryOlejnik, TeresaMultani, Pratik S and White, Christine A
Journal of Clinical Oncology, vol. 20, (no. 15), pp. 3262-9, 2002/Aug/1. | Journal Article
 
Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma.
Gordon, Leo IWitzig, Thomas EWiseman, Greg AFlinn, Ian WSpies, Stewart SSilverman, Daniel HEmmanuolides, ChristosCripe, LarrySaleh, MansoorCzuczman, Myron SOlejnik, TeresaWhite, Christine A and Grillo-López, Antonio J
Seminars in oncology, vol. 29, (no. 1S2), pp. 87-92, February 2002. | Journal Article
 
Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma.
Gordon, Leo IWitzig, Thomas EWiseman, Greg AFlinn, Ian WSpies, Stewart SSilverman, Daniel HEmmanouilides, ChristosCripe, LarrySaleh, MansoorCzuczman, Myron SOlejnik, TeresaWhite, Christine AGrillo-López, Antonio J and Emmanuolides, Christos
Seminars in oncology, vol. 29, (no. 1 Suppl 2), pp. 87-92, 2002/Feb. | Journal Article
2000
Acute myeloid leukemia in adults.
Cripe, Larry D and Hinton, S
Current Treatment Options in Oncology, vol. 1, (no. 1), pp. 9-17, 2000/Apr. | Journal Article
 
Hyperleukocytic Leukemias and Leukostasis: A Review of Pathophysiology, Clinical Presentation and Management
Porcu, PPorcu, PierluigiCripe, Larry DCripe, L DNg, E WNg, Elizabeth WBhatia, SumeetBhatia, SDanielson, C MDanielson, Constance MOrazi, AttilioOrazi, AttilioMcCarthy, L J and McCarthy, Leo J
Leukemia & Lymphoma, vol. 39, (no. 1-2), pp. 18, 20000000. | Journal Article
 
Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia: A study of the Eastern Cooperative Oncology Group (ECOG), E5995
Gordon, Michael SGordon, Michael SYoung, Molly LYoung, M LTallman, Martin STallman, Martin SCripe, L DCripe, Larry DBennett, John MBennett, John MPaietta, ElisabethPaietta, Elisabeth MLongo, WalterLongo, WGerad, HGerad, HenryMazza, JMazza, JosephRowe, J M and Rowe, Jacob M
Leukemia Research, vol. 24, (no. 10), pp. 875, 2000. | Journal Article
1999
A hot-start reverse transcription-polymerase chain reaction protocol that initiates multiple analyses simultaneously.
Tanzer, L RHu, YCripe, L and Moore, R E
Analytical biochemistry, vol. 273, (no. 2), pp. 307-310, September 10, 1999. | Journal Article